Search research articles
Contact Us
Filters
Showing results (971-980 of 1,398) with videos related to
Page
of 140
Sort By:
Tissue Antigens
|
April 1, 1997
Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy
E Mignot, A Kimura, A Lattermann, et al.
Clinical and Experimental Immunology
|
January 1, 2010
Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies
J Beauté, P Levy, V Millet, et al.
Brain & Development
|
March 24, 2010
A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients
Ichraf Kraoua, Frédéric Sedel, Catherine Caillaud, et al.
Peptides
|
January 22, 2003
Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background
L Lin, J Wisor, T Shiba, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 5, 2008
Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions
Evelyn Ullrich, Mathieu Bonmort, Gregoire Mignot, et al.
The Journal of Pathology
|
March 26, 2011
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
Sylvain Ladoire, Grégoire Mignot, Sandrine Dabakuyo, et al.
Nature Immunology
|
June 30, 2014
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
Frédérique Végran, Hélène Berger, Romain Boidot, et al.
JAMA Neurology
|
July 7, 2020
Association of Rapid Eye Movement Sleep With Mortality in Middle-aged and Older Adults
Eileen B Leary, Kathleen T Watson, Sonia Ancoli-Israel, et al.
Clinical Genetics
|
December 29, 2019
Three novel patients with epileptic encephalopathy due to biallelic mutations in the PLCB1 gene
Camille Desprairies, Stéphanie Valence, Hélène Maurey, et al.
Oncoimmunology
|
May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
Romain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Page
of 140
Search research articles
Search
Showing results (971-980 of 1,398) with videos related to
Sort By:
Page
of 140
Tissue Antigens
|
April 1, 1997
Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy
E Mignot, A Kimura, A Lattermann, et al.
Clinical and Experimental Immunology
|
January 1, 2010
Economic evaluation of immunoglobulin replacement in patients with primary antibody deficiencies
J Beauté, P Levy, V Millet, et al.
Brain & Development
|
March 24, 2010
A French experience of type 3 Gaucher disease: Phenotypic diversity and neurological outcome of 10 patients
Ichraf Kraoua, Frédéric Sedel, Catherine Caillaud, et al.
Peptides
|
January 22, 2003
Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background
L Lin, J Wisor, T Shiba, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 5, 2008
Trans-presentation of IL-15 dictates IFN-producing killer dendritic cells effector functions
Evelyn Ullrich, Mathieu Bonmort, Gregoire Mignot, et al.
The Journal of Pathology
|
March 26, 2011
In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
Sylvain Ladoire, Grégoire Mignot, Sandrine Dabakuyo, et al.
Nature Immunology
|
June 30, 2014
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
Frédérique Végran, Hélène Berger, Romain Boidot, et al.
JAMA Neurology
|
July 7, 2020
Association of Rapid Eye Movement Sleep With Mortality in Middle-aged and Older Adults
Eileen B Leary, Kathleen T Watson, Sonia Ancoli-Israel, et al.
Clinical Genetics
|
December 29, 2019
Three novel patients with epileptic encephalopathy due to biallelic mutations in the PLCB1 gene
Camille Desprairies, Stéphanie Valence, Hélène Maurey, et al.
Oncoimmunology
|
May 10, 2019
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
Romain-David Seban, Charlotte Robert, Laurent Dercle, et al.
Page
of 140